England & Company

England & Company is pleased to announce that Collagen Solutions has agreed to be acquired by RTI Surgical®, a portfolio company of Montagu Private Equity. Collagen Solutions provides OEM customers with high-quality medical devices and components made from collagen and xenograft tissue for various therapeutic areas, including cardiovascular, wound care, orthopedics and sports medicine, dental, biosurgery, and neurosurgery. Collagen Solutions' customers include global Fortune 500 companies as well as emerging innovators and mid-sized "challengers." Read the full news release here: https://lnkd.in/g3gatTjA #biomaterials #biosurgery #cardiovascular #dental #medicaldevice #regenerativemedicine #neurosurgery #orthopedics #sportsmedicine #woundhealing

We have just published the latest edition of MedDevNews, our quarterly review of capital markets activity and trends in the medical device sector. Medtech valuations decreased in Q2 2024, and while investments in the medical device sector have been under pressure since 2021, Q2 U.S. private financing trends indicate a promising path toward sustained growth. Read the full Q2 newsletter here: https://lnkd.in/ezrv2C3m #interventionalcardiology #medtech #philipssettlement #FDA #TTVR #medtechvaluations #medicaldevices

England & Company thanks our 2024 summer analysts for their contributions to our team over the last few months. We wish these talented individuals a year of success as they return to their universities. #internship #mentorship #summeranalysts

England & Company served as the exclusive financial advisor to Allied Bolt Products, LLC, in its sale to Power Grid Components, Inc., a portfolio company of Blackstone. "I am very thankful to England & Company for putting the deal between Allied Bolt and Power Grid Components together. There is no way we could have gotten to the finish line without them. They were incredibly knowledgeable, helpful, and patient in making our transaction go smoothly,” said Glen Malin, President of Allied Bolt.   Read the full news release: https://lnkd.in/diQ3G_hi #utilities #utility #telecommunication #mergersandacquisitions #energytransition

England & Company marked a significant milestone in 2023 – our 20th anniversary!   Throughout the year, we remained dedicated to our clients’ success by arranging financings to fuel business growth and unlocking value through M&A and recapitalization transactions. We also extended our platform to Asia-Pacific and expanded our offering of advisory services.   As we embark on our third decade, we express our sincere gratitude to our clients for their continued trust. Here's a look back at some of 2023's highlights... https://lnkd.in/g7-rc4aT     #mergersandacquisitions #recapitalizations #privateequity #capitalmarkets #englandco #middlemarketadviosry #investmentbanking

England & Company welcomes Richard F. NeJame as a Managing Director in our New York office. With over 25 years of experience as a corporate restructuring advisor focusing on leveraged finance, distressed M&A advisory, and capital raising for special situations, Rich will lead the firm’s Capital Structure Advisory practice. Read Rich’s full announcement here: https://lnkd.in/gjSiy3rS #bankruptcy #corporaterestructuring #capitalraising #leveragedfinance #recapitalization #restructuring

We recently advised OneroRx on its recapitalization by Cyprium Partners and Wells Fargo Bank. OneroRX is a leading technology-enabled, integrated pharmacy services company operating community pharmacies and telepharmacies in underserved rural and urban areas in the Midwest. Their efficient operations enable them to re-establish pharmacy care in these neglected markets, immediately and positively impacting community health and wellness. Read the full announcement here: https://lnkd.in/gX78VU5T   #telehealth #communitypharmacy #accessiblehealthcare #recapitalization #privateequity #healthcareinvestment

England & Company welcomes Joel Strauch as new Managing Director in our Washington, DC office. With over 25 years of experience advising infrastructure and software companies on M&A, strategic growth, and capital raising, Joel will lead the expansion of the firm's technology practice. Read Joel’s full announcement here: https://lnkd.in/gAHik98s #newhirespotlight #mergersandacquisitions #venturecapital  #saas #ai #cloudsoftware #managedservices #technologyinvestment #privateequity

We recently advised Powerside on its growth equity financing provided by Energy Growth Momentum. Powerside plays a pivotal role in advancing the transformation of the industrial and utility electric power infrastructure with its unique ability to analyze, detect, and correct power quality issues arising from the increase in electric vehicles, a more distributed energy resource mix, and more renewable generation. Read the full announcement here: https://lnkd.in/e2Ana9w6 #GreenMobility #EVCharging #powerquality #energytransition #renewableenergy

England & Company is pleased to announce the closing of several strategic and financial transactions for Extremity Medical in 2023. Extremity Medical has entered into a strategic relationship with Henry Schein (NASDAQ: HSIC). The relationship is part of Henry Schein’s expansion in orthopedics and complementary to Schein’s pending acquisition of TriMed, Inc. England also closed a total of $21 million in convertible note and working capital financings for Extremity Medical between June and November of this year. Extremity Medical will use the new capital provided by its latest financing to invest in the growth of its business and refinance existing debt.     Read the full announcement here: https://lnkd.in/gvHY5sgq